Research found that combining arsenic trioxide with ABT-737 can enhance mitochondrial apoptosis and downregulation of Mcl-1 in cervical cancer cells, leading to a synergistic lethal impact (Hsin et al., 2019). The gene discussed is MCL1; the disease is cervical carcinoma.